NEW YORK, March 17 (Reuters) - Activist investor Altai Capital Management called on OraSure Technologies to explore a sale, saying the medical device maker could fetch double its current share price.

Altai Has Rejected All Settlement Proposals and Is Singularly Focused on Securing Board Representation for Its Founder to Force an Ill-Timed Sale Process BETHLEHEM, Pa., March 17, 2026 (GLOBE NEWSWIRE ...

Update 5:15pm: Adds OraSure response. Activist investor Altai Capital is pushing for OraSure Technologies (OSUR) to pursue a potential sale that could result in the doubling of the medical device ...

Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026 Highlights Extensive Engagement with Altai Altai Has Rejected All ...

After increasing its stake in the infectious disease testmaker last year, Altai Capital Management is now pushing OraSure Technologies to consider the sale of its entire business, along with a shift ...

NEW YORK, March 17 (Reuters) - Activist investor Altai Capital Management called on OraSure Technologies (OSUR.O), opens new tab to explore a sale, saying the medical device maker could fetch double ...

LOS ANGELES - Altai Capital Management, which owns approximately 5% of OraSure Technologies Inc. (NASDAQ:OSUR), delivered a letter to the company’s board today calling for the appointment of two ...

Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance Calls on Company to Reach a Fair Settlement that ...

TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- AltaiResources Inc. (TSXV: ATI) ("Altai” or the "Company”) announced today that the common shares of the Company (the "Common Shares”) will resume trading on ...